Week March 19th, 2004 through march 25th, 2004

Remember to Login to capitalhunter.com using your username and password to see all of the latest updates!

Over $499 million of venture capital was invested in 31 U.S.-based companies during this reporting period. The average deal size was approximately $16.1 million. The amount of venture capital invested this period is up 112% from last week's $235 million.

Geographically, 11 California companies raised $348 million in venture financings. The largest venture financing in California this period was by Jazz Pharmaceuticals, Inc. for $250 million. Jazz Pharmaceuticals, Inc. is located in Palo Alto, CA and is a drug company concentrated on neurological and psychiatric disorders.

The Biotech sector raised 56% of the venture capital this period. 6 Biotech companies raised $279.7 million in venture financings. The largest venture financing in the Biotech sector this period was by Jazz Pharmaceuticals, Inc. To learn more about this deal and many others please visit www.capitalhunter.com and obtain a free two week trial to our service.

Companies raising their Series B round of funding represented 65% of the total venture capital deployed this period. The largest Series B round financing was by Jazz Pharmaceuticals, Inc.

The three largest venture deals this period are as follows:

The following fifteen investors funded the above mentioned top three venture capital investments in excess of $288 million:

A total of 66 equity financings of private and public companies occurred during this reporting period. The equity financings included in our weekly report that you can obtain as a subscriber are of angel, venture capital, PIPE, secondary and initial public equity offers. If you are interested in obtaining detailed information about any of these or historic financings please go to www.capitalhunter.com and get immediate access for only $19.95 per month.

To be REMOVED from this free service, CLICK HERE